Cargando…
Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI
Background: Despite its frequency, the polycystic ovary syndrome (PCOS) is still a difficult diagnosis in endocrinology, gynecology, and reproductive medicine. The Rotterdam consensus conference proposed to include the ultrasonographic follicle count as a new diagnostic criterion. Unfortunately, its...
Autores principales: | Swellam, Menha, Khaial, Abeer, Mosa, Tamer, El-Baz, Hatim, Said, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research and Clinical Center for Infertility
2013
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941393/ https://www.ncbi.nlm.nih.gov/pubmed/24639712 |
Ejemplares similares
-
Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018) -
Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI
por: Sun, Bo, et al.
Publicado: (2021) -
Serum anti-Müllerian hormone levels are associated with early miscarriage in the IVF/ICSI fresh cycle
por: Liu, Xin, et al.
Publicado: (2022) -
Androgen and Anti-Mullerian Hormone Concentrations at Term in Newborns and Their Mothers with and without Polycystic Ovary Syndrome
por: Kollmann, Martina, et al.
Publicado: (2019) -
Serum anti-Müllerian hormone levels are associated with perinatal outcomes in women undergoing IVF/ICSI: A multicenter retrospective cohort study
por: He, Yi-Chen, et al.
Publicado: (2023)